Latest filing published 18 Mar 2021 for Gene Biotherapeutics, Inc., €10k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Christopher J. Jemapete: trading record in brief
All filings by Christopher J. Jemapete on record concern Gene Biotherapeutics, Inc. The record holds 2 filings, for trades running from 16 March 2021 to 17 March 2021.
The open-market record is one-sided, with 2 purchases worth €78k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 18 March 2021: an open-market purchase of €10k, in Gene Biotherapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher J. Jemapete
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300,000 shares@ US$0.039912.9% of flowCommon StockSEC:0001493152-21-006314:0Canonical exit: 14 Jun 2021 (T+90)
- 200,000 shares@ US$0.40287.1% of flowCommon StockSEC:0001493152-21-006314:1Canonical exit: 15 Jun 2021 (T+90)
2 of 2 declarations